Article
Noninvasive long-term ventilatory support for individuals with spinal muscular atrophy and functional bulbar musculature

https://doi.org/10.1016/S0003-9993(95)80603-2Get rights and content

Abstract

Ten individuals with spinal muscular atrophy (SMA) and chronic ventilatory insufficiency were trained in the use of assisted coughing techniques and received intermittent positive pressure ventilation (IPPV) via oral and/ or nasal interfaces for a mean of 5.3 (range = 1 to 17) years. During this time they had significantly fewer respiratory complications than before introduction of noninvasive respiratory muscle aids despite the fact that 6 of the 10 went on to require more than 20 hours per day of ventilator use with less than 2 hours of ventilator-free breathing time (VFBT). All except two noninvasive IPPV users had vital capacities (VCs) less than 13% of predicted normal. They could, however, communicate verbally and take nutrition by mouth. All of the patients remained in the community. Five patients were gainfully employed and four were in school. We conclude that noninvasive respiratory muscle aids including noninvasive IPPV and assisted coughing techniques are effective and practical alternatives to tracheostomy for SMA patients with ventilatory failure but functional bulbar musculature.

Cited by (32)

  • Standard of Care for Spinal Muscular Atrophy

    2017, Spinal Muscular Atrophy: Disease Mechanisms and Therapy

  • The Respiratory System and Neuromuscular Diseases

    2015, Murray and Nadel's Textbook of Respiratory Medicine: Volume 1,2, Sixth Edition

  • Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases

    2012, Physical Medicine and Rehabilitation Clinics of North America
    Citation Excerpt :

    Although no survival data exist for patients with SMA III, cases have been followed into the eighth decade without mechanical ventilation.52,66 Ventilatory failure due to neuromuscular restrictive lung disease is a rare event in SMA III, occurring only in adulthood.18,52 Zerres and Rudnik-Schoneborn66 have proposed further subtypes, including SMA IIIa (walks without support; age of onset before 3 years) and SMA IIIb (walks without support; age of onset 3–30 years).

  • Noninvasive positive pressure ventilation in the treatment of hypoventilation in children

    2010, Sleep Medicine Clinics
    Citation Excerpt :

    For SMA patients, NPPV can be provided as routine therapy or as a palliative tool. NPPV can be used to achieve adequate inspiratory chest wall expansion and air entry, and normalization of gas exchange.76,80–82 In a randomized controlled trial using mixed groups of patients with NMD with nocturnal hypoventilation and daytime normocapnia, noninvasive ventilation significantly improved nocturnal blood gas tensions.76

  • Diagnosis and Clinical Management of Spinal Muscular Atrophy

    2008, Physical Medicine and Rehabilitation Clinics of North America
    Citation Excerpt :

    In addition, SMA II patients showed more severe declines in maximal expiratory pressure versus maximal inspiratory pressure, suggesting relative diaphragmatic sparing [53,77–79]. Progressive restrictive lung disease in SMA III was shown to be mild and rarely necessitated the institution of ventilatory support [17,37,80–83]. Although no specific spirometry parameters for beginning ventilatory support have been established, it has been found that the institution of mechanical ventilation in SMA II was generally not required until FVC was about 20% of the predicted value [81,84].

  • Sleep-Disordered Breathing in Children

    2005, Pediatric Pulmonology: The Requisites
View all citing articles on Scopus

No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.

View full text
Copyright © 1995 Published by Elsevier Inc.